BioCentury | Jan 9, 2018
Distillery Therapeutics

Autoimmune disease

...β (NR1H2; LXRβ) agonist, to treat atopic dermatitis. Ralexar Therapeutics Inc. has the LXR agonist ALX-101...
BioCentury | Apr 14, 2016
Distillery Therapeutics

Therapeutics: Liver X receptor (LXR)

...Phase II/III testing to treat Niemann-Pick disease type C1 (NPC1) . Alexar Therapeutics Inc. has ALX-101...
BioCentury | Dec 7, 2015
Clinical News

ALX-101: Phase IIa started

...levels of ALX-101 topical gel in 72 patients. Alexar Therapeutics Inc. , Malvern, Pa. Product: ALX-101...
Items per page:
1 - 3 of 3